When you join our program, you are under strict clinician oversight
Allergy 70 , 727754 (2015)
Form Blends offers physician-supervised GLP-1 weight loss with compounded semaglutide, tirzepatide, and peptide wellness therapy
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was initially approved in 2020 as a treatment method for improving glycemic control in patients with Type 2 diabetes
Taken together, the observed lack of association between the use of GLP-1 RA and suicide or suicide attempts reflects the absence of increased suicide risk, even when accounting for the acknowledged limitations
In controlled studies using aging C57BL/6J mice, supplementation beginning at 65 weeks increased lifespan by 23.7% (104.0 vs